Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADHD: Medication or Meditation?
2013-003888-59Phase 4Active
- Sponsor
- University of Amsterdam
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by University of Amsterdam. Primary endpoint: Primary ADHD symptom outcomes. Started Jan 2014; status: active.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on 2013-003888-59.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003888-59.